Evidence map›Paper›PMID 40679401›Full record

ReviewCurrent opinion in hematology2025

Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells.

Divya Beri, Marilis Rodriguez, Cheryl A Lobo

Abstract readReview
In one paragraph

Review in Current opinion in hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Divya BeriDepartment of Blood-Borne Parasites, Lindsley F. Kimball Research Institute, New York Blood Center, New York, USA.
Marilis Rodriguez
Cheryl A Lobo

Funding

Sickle cell bone marrow niche and regulation of platelet activation and erythropoiesisP01HL149626 · NHLBI · NEW YORK BLOOD CENTER · PI Cheryl Ann Lobo · 2020 to 2026
$24.4M
Designing a Robust Platform for the In vitro Propagation of Babesia Microti in Human RBCsR61AI187095 · NIAID · NEW YORK BLOOD CENTER · PI Cheryl Ann Lobo · 2025 to 2026
$854k
Structural and Functional Alteration of host RBCs by BabesiaK99AI182422 · NIAID · NEW YORK BLOOD CENTER · PI Divya Beri · 2025 to 2026
$269k
NHLBI NIH HHS P01 HL149626NIAID NIH HHS K99 AI182422NIAID NIH HHS R61 AI187095
6 · The paper itself

Abstract

purpose of reviewMalaria and babesiosis are important transfusion-transmitted diseases, therefore, it is important to report novel insights into the complex interactions the causative parasites share with their common host RBCs. Metabolomics is an important tool that can be used to reveal an in-depth analysis of parasite infections in the context of the host. Similarities and differences in the biochemical fingerprints between malaria and babesia infected RBCs are reviewed with potential reasons for these differences and implications for the host. RECENT

findingsRecent results from Babesia-infected RBCs offer an opportunity to develop comparative models of pathogenesis for both infections. Perturbation in the levels of key biomolecules including sugars, amino-acids and lipids, along with redox homeostasis, and heme utilization, are hallmarks of both diseases. Key similarities include enhanced glycolytic rate in both infected RBCs together with lipid scavenging from RBC membranes. Differences relate to hemoglobin breakdown and the use of resultant amino acids for propagation. SUMMARY: Altered metabolic profiles reflect the unique lifecycles of Plasmodium and Babesia, pointing to how they carve out a niche for successful proliferation. A comprehensive understanding of the metabolic similarities and differences between the two parasites will aid in identifying new biomarkers as well as specific, effective targeted therapies.

Indexed as

BabesiaBabesiosisErythrocytesHost-Parasite InteractionsMalariaMetabolomeMetabolomicsPlasmodiumAnimalsHumansBabesiahemoglobinhost-parasitelipidsmalariametabolomics

Identifiers

PMID40679401
PMCPMC12425148

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.